Table 4.

Combination therapies with hypomethylating agents in patients with MDS

Combination therapies with hypomethylating agents in patients with MDS
Combination therapies with hypomethylating agents in patients with MDS

Combination studies were reviewed in Ornstein and Sekeres.54 

N indicates number of patients; and ORR, overall response rate.

*Decrease in hemorrhagic events.

or Create an Account

Close Modal
Close Modal